News
- Author:
- Amy Karon
Publish date: March 17, 2014
Major finding: About 7.4% of coinfected patients and 4.8% of monoinfected patients had hepatic decompensation at 10 years (hazard ratio, 1.56; 95%...
News
- Author:
- Amy Karon
Publish date: March 17, 2014
Major finding: Performance ranking changed for 28% of hospitals when calculations of risk-standardized pneumonia mortality rates included patients...
News
- Author:
- Amy Karon
Publish date: March 17, 2014
Major finding: About 7.4% of coinfected patients and 4.8% of monoinfected patients had hepatic decompensation at 10 years (hazard ratio, 1.56; 95%...
News
- Author:
- Amy Karon
Publish date: March 17, 2014
Major finding: Positive surgical margins were not significantly associated with prostate cancer–specific mortality within 15 years of radica...
News
- Author:
- Amy Karon
Publish date: March 14, 2014
Major Finding: Patients receiving palliative chemotherapy were more likely to undergo mechanical ventilation, cardiopulmonary resuscitation, or bo...
News
- Author:
- Amy Karon
Publish date: March 14, 2014
Major Finding: Relapse rates after patients switched to fingolimod were low (quarterly relapse rate range, 0.079-0.13). Predictors of time to firs...
News
- Author:
- Amy Karon
Publish date: March 14, 2014
Major finding: Overall incidence of incidental gallbladder cancer was 0.19%. Risk factors included open vs.
News
- Author:
- Amy Karon
Publish date: March 12, 2014
Major finding: Adjuvant fluorouracil-based chemotherapy after preoperative radiotherapy did not affect disease-free survival or overall survival, ...
News
- Author:
- Amy Karon
Publish date: March 11, 2014
Major finding: Targeted therapy was possible for 13% of patients screened with genomic analyses.
News
- Author:
- Amy Karon
Publish date: March 11, 2014
Major finding: The median overall survival was 13.6 months for patients receiving vemurafenib compared with 9.7 months for patients receiving daca...
News
- Author:
- Amy Karon
Publish date: March 11, 2014
Major finding: At 1-year follow-up, 3% of the vaginal mesh group met criteria for anatomic failure, compared with 62%-65% of the sacrospinous vagi...
News
- Author:
- Amy Karon
Publish date: March 10, 2014
Major finding: 74 of 83 patients (89%) reported at least 50% improvement after 12 weekly sessions of percutaneous tibial nerve stimulation.
News
- Author:
- Amy Karon
Publish date: March 7, 2014
Major finding: At 6 years of follow-up, patients receiving 100 mg dasatinib daily had an overall survival of 71% and progression-free survival of ...
News
- Author:
- Amy Karon
Publish date: March 4, 2014
Major Finding: Long-term hormone therapy was associated with significantly improved survival in women with non–small-cell lung cancer (HR, 0...
